Your browser doesn't support javascript.
loading
Downregulated calmodulin expression contributes to endothelial cell impairment in diabetes.
Liu, Tian-Tian; Xu, Huan-Huan; Liu, Ze-Juan; Zhang, He-Ping; Zhou, Hai-Tao; Zhu, Zhi-Xiang; Wang, Zhi-Qiang; Xue, Jing-Yi; Li, Qiang; Ma, Yi; You, Hong-Jie; Luo, Da-Li.
Afiliação
  • Liu TT; Department of Pharmacology, Beijing Key Laboratory of Cardiovascular Diseases Related to Metabolic Disturbance, Capital Medical University, Beijing, 100069, China.
  • Xu HH; Department of Pharmacology, Beijing Key Laboratory of Cardiovascular Diseases Related to Metabolic Disturbance, Capital Medical University, Beijing, 100069, China.
  • Liu ZJ; Department of Pharmacology, Beijing Key Laboratory of Cardiovascular Diseases Related to Metabolic Disturbance, Capital Medical University, Beijing, 100069, China.
  • Zhang HP; Beijing Friendship Hospital, The Affiliated Hospital of Capital Medical University, Beijing, 100065, China.
  • Zhou HT; National Cancer Center, National Clinical Research Center for Cancer, Cancer Hospital, and Peaking Union Medical College, Chinese Academy of Medical Sciences, Beijing, 100021, China.
  • Zhu ZX; National Cancer Center, National Clinical Research Center for Cancer, Cancer Hospital, and Peaking Union Medical College, Chinese Academy of Medical Sciences, Beijing, 100021, China.
  • Wang ZQ; Department of Pharmacology, Beijing Key Laboratory of Cardiovascular Diseases Related to Metabolic Disturbance, Capital Medical University, Beijing, 100069, China.
  • Xue JY; Department of Pharmacology, Beijing Key Laboratory of Cardiovascular Diseases Related to Metabolic Disturbance, Capital Medical University, Beijing, 100069, China.
  • Li Q; Department of Pharmacology, Beijing Key Laboratory of Cardiovascular Diseases Related to Metabolic Disturbance, Capital Medical University, Beijing, 100069, China.
  • Ma Y; Department of Pharmacology, Beijing Key Laboratory of Cardiovascular Diseases Related to Metabolic Disturbance, Capital Medical University, Beijing, 100069, China.
  • You HJ; Department of Pharmacology, Beijing Key Laboratory of Cardiovascular Diseases Related to Metabolic Disturbance, Capital Medical University, Beijing, 100069, China.
  • Luo DL; Department of Pharmacology, Beijing Key Laboratory of Cardiovascular Diseases Related to Metabolic Disturbance, Capital Medical University, Beijing, 100069, China. luodl@ccmu.edu.cn.
Acta Pharmacol Sin ; 44(12): 2492-2503, 2023 Dec.
Article em En | MEDLINE | ID: mdl-37468692

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article